CBD Life Sciences Inc. (OTCMKTS: CBDL) is up 25%. Recently the company announced an expansion of its product line through its subsidiary LBC Biosciences Inc. with the launch of a new pain relief cream. The company is working on a stronger 3000MG Pain Relief Cream Relative to its top-selling 2000MG cream.
CND Life Sciences launches a more potent pain relief cream
Lisa Nelson, the company’s CEO, said, “Whether you are throwing touchdowns or making big plays in the conference room, you need a CBD cream that can compete. Moreover, you need a CBD topical that can give you immediate relief. Because sometimes your body screams for urgent care.”
It is always potent with 3000mg of CBD since it doesn’t generate a psychoactive effect. This CBD Pain Cream is jam-packed with the advantages of high-quality CBD extract. Also, it’s a top-notch CBD Pain Relief cream with no psychotropic side effects. You may now target your problem areas instantly and effectively. Athletes, chiropractors, physicians, and massage therapists are among the clientele targeted by CBD Life Sciences Inc. Most importantly, CBD creams are a superior pain relief option to CBD oil because they can be applied directly to the location of discomfort.
CBD Life Sciences opens second retail location
The company announced the launch of its second retail location o June 12, 2021, through its subsidiary. Ms. Nelson said, “We had our official Grand Opening of The CBD Vault on June 12th and we could not be any happier with the positive response we received from all the customers. We sold out of all 4 of our new strains of Delta-8 cartridges (Strawberry Cough, Blue Dream, Pineapple Express, Zkittles) within the first hour of opening. Over 200 customers came in and out to celebrate and it turned out to be an incredibly good event and we are beyond satisfied with the results.”
